Mediterranean spotted fever in Portugal: Risk factors for fatal outcome in 105 hospitalized patients

Annals of the New York Academy of Sciences

Volumn 990, Issue , 2003, Pages 285-294

  De Sousa, Rita ^a   Dória Nóbrega, Sónia ^b   Bacellar, Fátima ^a   Torgal, Jorge ^c  

^a NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^b INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

^c UNIVERSITY OF LISBON   (Portugal)

Author keywords

Mediterranean spotted fever; Mortality rates; Portugal; Risk factors

Indexed keywords

ADOLESCENT; ADULT; AGED; BOUTONNEUSE FEVER; CHILD; CLINICAL FEATURE; CLINICAL LABORATORY; CONFERENCE PAPER; DEHYDRATION; DIABETES MELLITUS; FATALITY; FEMALE; GEOGRAPHIC DISTRIBUTION; HIGH RISK PATIENT; HUMAN; INFESTATION; ISRAELI TICK TYPHUS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; PORTUGAL; PREVALENCE; RICKETTSIA; RICKETTSIA CONORII; RICKETTSIOSIS; RISK FACTOR; UREMIA; VOMITING;

ACARI; RICKETTSIA; RICKETTSIA CONORII; RICKETTSIALES;

EID: 0038390985     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2003.tb07378.x     Document Type: Conference Paper

References (30)

1. MUMCUOGLU, K.Y., A. KEYSARY & L. GILEAD. 2002. Mediterranean spotted fever in Israel: a tick-borne Disease. Isr. Med. Assoc. J. 4: 44-49.
2. WALKER, D.H. et al. 1987. The Pathology of Fatal Mediterranean Spotted Fever. Am. J. Clin. Pathol. 87:669-672.
3. SOUSA, R. 2002. Sobre a Realidade Epidemiológica da Febre Escaro-nodular. MSc. Thesis, Universidade Nova de Lisboa, Lisboa.
4. AHARONOWITZ, G. et al. 1999. Epidemiological characteristics of spotted fever in Israel over 26 years. Clin. Infect. Dis. 29:1321-1322.
5. BACELLAR, F.C. et al. 1999. Israeli spotted fever Rickettsia (Rickettsia conorii complex) associated with humam diseses in Portugal. Emerg. Infect. Dis. 5(6): 835-836.
6. RAOULT, D. et al. 1986. Mediterranean spotted fever: clinical, laboratory, and epidemiological features of 199 cases. Am. J. Trop. Med. Hyg. 35: 845-850.
7. RAOULT, D. et al. 1986. Incidence, clinical observations and risk factors in the severe form of mediterranean spotted fever among patients admitted to hospital in Marseilles 1983-1984. J. Infect. Dis. 12: 111-116.
8. FONT-CREUS, B. et al. 1985. Mediterranean spotted fever. A cooperative study of 227 cases. Rev. Infect. Dis. 7: 635-642.
9. FONT-CREUS, B. et al. 1991. Fiebre botonosa mediterránea. Estudio de 246 casos. 96: 121-125.
10. BROUQUI, P. et al. 1992. Spotless boutonneuse fever. Clin. Infect. Dis. 14: 114-116.
11. LANCET (editorial). 1991. Bitten, hot, and mostly spotty. Lancet 337: 143-144.
12. RAOULT, D. & V. ROUX. 1997. Rickettsiosis as paradigms of new or emerging infectious diseases. Clin. Microbiol. Rev. 10(4): 694-719.
13. GROSS, E.M. & P. YAGUPSKY. 1987. Israeli rickettsial spotted fever in children. A review of 54 cases. Acta Trop. 44: 91-96.
14. REGEV-YOCHAY, G., E. SEGAL & E. RUBINSTEIN. 2000. Glucose-6-phosphate dehydrogenase deficiency: possible determinant for a fulminant course of Israeli spotted Fever. Isr. Med. Assoc. J. 2: 781-782.
15. DGS-SERVIÇO DE INFORMAÇÃO DE SAÚDE. Doenças de Declaração Obrigatória 1989-1998. Ministério da Saúde, Direcção Geral da Saúde, Lisboa, Portugal.
16. Gilot, B. et al. 1990. Relationships between the Rhipicephalus sanguineus complex ecology and Mediterranean Spotted Fever Epidemiology in France. Eur. J. Epidemiol. 6(4): 357-362.
17. CAEIRO, V. 1992. As carraças em Portugal: seus hospedeiros domésticos e silvestres. Ciclos vitais, preferências de vegetação e de clima. Med. Vet. 28: 7-25.
18. CAEIRO, V. 1999. General review of tick species present in Portugal. Parassitologia (Rome) 41(Suppl.1): 11-15.
19. FRANÇA, A. et al. 2000. Fatal Mediterranean spotted fever in Portugal. Similarities with RMSF. Presented at International Conference on Emerging Infectious Diseases. Atlanta, Georgia, USA, July 16-19.
20. GOLDWASSER, R.A. et al. 1974. The Isolation of strains of rickettsiae of the spotted fever group in Israel and their differentiation from another members of the group by immunofluorescence methods. Scand. J. Infect Dis. 6: 53-62.
21. RUIZ-BELTRAN, R. et al. 1985. Formas graves de fiebre exantemática mediterránea. Análisis prospectivo de 71 enfermos. An. Med. Interna. II: 365-368.
22. JUFRESA, J. et al. 1997. Study of 86 of Mediterranean boutonneuse fever hospitalized at a university hospital. An. Med. Interna. 14(7): 325-327.
23. GRILLO-REINA, A. et al. 1982. Fiebre botonosa. Estudio de los factores pronósticos. Rev. Clin. Esp. 164: 387-390.
24. ROUSSEAU, M.C., P. BROUQUI & S. BOURGEADE. 1994. Fièvre boutonneuse méditerranéenne maligne chez un patient porteur d'un déficit partiel en glucose-6-phosphate-déshydrogénase. Rev. Méd. Interne. 15: 362-366.
25. RAOULT, D. et al 1986. Hemolysis with mediterranean spotted fever and glucose-6-phosphate-desidrogenase defficiency. Trans. Roy. Soc. Trop. Med. Hyg. 80: 961-962.
26. PIRAS, M.A. et al. 1983. Glucose 6-phosphate dehydrogenase deficiency in male patients with mediterranean spotted fever in Sardinia. J. Infect. Dis. 147: 607-608.
27. HOLMAN, R.C. et al. 2001. Analysis of risk factors for Rocky Mountain spotted fever: evidence for superiority of tetracyclines for therapy. J. Infect. Dis. 184: 1437-1444.
28. KIRKLAND, B.K., W.E. WILKINSON & D.J. SEXTON. 1995. Therapeutic delay and mortality in cases of Rocky Mountain spotted fever. Clin. Infect. Dis. 20: 1118-1121.
29. MAURIN, M. & D. RAOULT. 1999. Antimicrobial therapy of rickettsial diseases. Proceedings of Rickettsiae and Rickettsial Diseases at the Turn of the Third Millenium. D. Raoult & P. Brouqui. Elsevier.
30. RUIZ-BELTRAN, R. & J.L. HERRERO-HERRERO. 1992. Deleterious effect of trimetrhoprim-sulfamethoxazol in Mediterranean spotted fever (letter). Antimicrob. Agents Chemother. 36: 1342-1344.